Home › Funds › Artia Global Partners LP › DGX
Artia Global Partners LP position in DGX
QUEST DIAGNOSTICS INC · Health Care
Artia Global Partners LP reported holding 65,122 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$13.8M, representing 2.55% of its reported portfolio and ranking #13 among its reported holdings. Artia Global Partners LP has disclosed DGX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's DGX position evolved
Artia Global Partners LP first disclosed a stake in DGX in Q1 2025 at 56,717 shares (US$9.6M). The position peaked in Q3 2025 at 81,717 shares, worth US$15.6M. Across 6 filings, Artia Global Partners LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 65,122 shares valued at US$13.8M — an increase of 24,305 shares quarter over quarter.. Notable position changes include a 44% increase in Q2 2025 (shares rose 6% over the following quarter), a 50% trim in Q4 2025 (shares rose 13% over the following quarter), a 60% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 56.72K | $9.60M | New |
| Q2 2025 | 81.72K | $14.68M | Add |
| Q3 2025 | 81.72K | $15.57M | Hold |
| Q4 2025 | 40.82K | $7.08M | Reduce |
| Q1 2026 | 40.82K | $8.00M | Hold |
| Q2 2026 | 65.12K | $13.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
- M&G Plc 795.65K sh · $168.68M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held DGX?
Artia Global Partners LP has disclosed DGX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Artia Global Partners LP's current position in DGX?
As of Q2 2026, Artia Global Partners LP holds 65.12K shares of DGX (QUEST DIAGNOSTICS INC), valued at $13.80M, representing 2.55% of its reported portfolio and ranking #13.
Has Artia Global Partners LP been buying or selling DGX?
In the latest 13F filing (Q2 2026), Artia Global Partners LP increased its position in DGX. The position peaked in Q3 2025 at 81.72K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.